KIMBERLY WEIER: Open Payments
NPI 1710609631 · AUBURN, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,448 in 54 payments from 20 companies in 2025. Trend: 2023 $0 · 2024 $478 · 2025 $1,448
Food & beverage: $1,448
| Company | Payments | Amount |
|---|---|---|
| BETA BIONICS, INC. | 10 | $446 |
| Novo Nordisk Inc | 13 | $219 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $92 |
| Amgen Inc. | 2 | $84 |
| Alexion Pharmaceuticals, Inc. | 3 | $75 |
| Insulet Corporation | 2 | $59 |
| Lilly USA, LLC | 2 | $58 |
| Medtronic, Inc. | 1 | $57 |
| Ascendis Pharma Endocrinology Inc | 2 | $51 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $43 |
Products named: iLet Bionic Pancreas, Ozempic, Kerendia, TEPEZZA, STRENSIQ, Wegovy, Omnipod, MINIMED 780G.
Industry payments across NY — which companies pay providers there.
